November 17: Developing Decision-Grade Real-World Evidence - In Person at ISPOR Europe 2024
November 17, 2024
Developing Decision-Grade Real-World Evidence (in person)
LEVEL: Intermediate
TRACK: Real World Data & Information Systems
LENGTH: 4 Hours
| Course runs 1 day
This short course is offered in-person at the ISPOR Europe 2024 conference. Separate registration is required. Visit the ISPOR Europe 2024 Program page to register and learn more.
Sunday, 17 November 2024 | Course runs 1 Day
08:00-12:00 Central European Time (CET)
DESCRIPTION
Separate registration required.
In this course, participants will be introduced to the principles of what makes real-world evidence (RWE) decision-grade, including an extended example. In the first half of the course, will review the most recent RWE frameworks and guidelines, and examine case studies in which RWE was used in regulatory and HTA approval. The second half of the course is an extended example in which participants will examine a study that could support an indication expansion, and interactively discuss how choices made in the design and implementation may affect the meaning and interpretability of results.
PREREQUISITE: Students are expected to be familiar with relevant concepts and methodologies for analyzing real-world data.
FACULTY MEMBERS
Sebastian Schneeweiss, MD, ScD
Professor of Medicine and Epidemiology, Harvard Medical School
and Chief, Division of Pharmacoepidemiology
Brigham and Women’s Hospital
Boston, MA, USA
Jeremy A. Rassen, ScD
Co-Founder & Chief Scientific Officer
Aetion, Inc.
New York, NY, USA
Shirley Wang, PhD
Associate Professor of Medicine
Division of Pharmacoepidemiology and Pharmacoeconomics
Department of Medicine, Brigham and Women’s Hospital
Harvard Medical School
Boston, MA, USA
Basic Schedule:
4 Hours | Course runs 1 Day